A first-ever tissue implant to safely treat a common jaw defect, temporomandibular joint dysfunction, has been successfully tested in animals by researchers from UC Irvine and UC Davis.
“We were able to show that we could achieve exceptional healing of the TMJ area after eight weeks of treatment,” said UCI Distinguished Professor of biomedical engineering Kyriacos Athanasiou, senior author on the study, published Wednesday in Science Translational Medicine. Athanasiou, who joined UC Irvine last year after several years at UC Davis’ Department of Biomedical Engineering, has been working on the condition for nearly two decades.
By Holly Ober
Two UC Davis graduates have started a company incubated in the TEAM manufacturing facility at the UC Davis Department of Biomedical Engineering.
Arshia Firouzi and Gurkern Sufi met in 2011 as Freshmen living in Tercero Dormitories at UC Davis and quickly became friends. Arshia majored in Electrical Engineering and Gurkern in Biotechnology, and they worked with the mentorship of Professor Marc Facciotti to explore their shared interest in the intersection of electronics and biology. In 2015 they won a VentureWell grant for a research project, which they pursued in TEAM’s Molecular Prototyping and Bioinnovation Laboratory. By the end of their project, they had come up with an idea that grew into a company that could usher in a new era for laboratories all over the world.